Confronting age-related macular degeneration. New drugs and treatments can retard progression of vision loss, though there is yet no definitive cure.
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use; D061067:Antibodies, Monoclonal, Humanized; D000975:Antioxidants / Q000627:therapeutic use*; D001205:Ascorbic Acid / Q000008:administration & dosage; D004359:Drug Therapy, Combination; D006801:Humans; D008268:Macular Degeneration / Q000145:classification / Q000175:diagnosis / Q000188:drug therapy*; D008875:Middle Aged; D000069579:Ranibizumab; D014810:Vitamin E / Q000008:administration & dosage; D019207:beta Carotene / Q000008:administration & dosage
D000911:Antibodies, Monoclonal; D061067:Antibodies, Monoclonal, Humanized; D000975:Antioxidants; D019207:beta Carotene; D014810:Vitamin E; D001205:Ascorbic Acid; D000069579:Ranibizumab